Baxter Bros Inc’s Idexx Laboratories IDXX Stock Holding History

Baxter Bros Inc’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$907K	Buy	1,723 +13	+0.8%	+$7.29K	0.1%	98
2026 Q1	$961K	Hold	1,710	–	–	0.12%	91
2025 Q4	$1.16M	Hold	1,710	–	–	0.13%	86
2025 Q3	$1.09M	Hold	1,710	–	–	0.13%	85
2025 Q2	$917K	Hold	1,710	–	–	0.11%	89
2025 Q1	$718K	Hold	1,710	–	–	0.09%	95
2024 Q4	$707K	Hold	1,710	–	–	0.09%	94
2024 Q3	$864K	Hold	1,710	–	–	0.11%	85
2024 Q2	$833K	Sell	1,710 -570	-25%	-$286K	0.11%	82
2024 Q1	$1.23M	Hold	2,280	–	–	0.16%	75
2023 Q4	$1.27M	Hold	2,280	–	–	0.18%	72
2023 Q3	$997K	Hold	2,280	–	–	0.15%	79
2023 Q2	$1.15M	Hold	2,280	–	–	0.17%	74
2023 Q1	$1.14M	Hold	2,280	–	–	0.18%	73
2022 Q4	$930K	Hold	2,280	–	–	0.15%	75
2022 Q3	$743K	Buy	2,280 +400	+21%	+$147K	0.13%	78
2022 Q2	$659K	Hold	1,880	–	–	0.12%	81
2022 Q1	$1.03M	Hold	1,880	–	–	0.15%	73
2021 Q4	$1.24M	Hold	1,880	–	–	0.18%	71
2021 Q3	$1.17M	Hold	1,880	–	–	0.19%	69
2021 Q2	$1.19M	Hold	1,880	–	–	0.19%	67
2021 Q1	$920K	Hold	1,880	–	–	0.16%	70
2020 Q4	$940K	Hold	1,880	–	–	0.18%	70
2020 Q3	$739K	Sell	1,880 -50	-3%	-$18.5K	0.16%	70
2020 Q2	$637K	Sell	1,930 -170	-8%	-$49.2K	0.15%	72
2020 Q1	$509K	Hold	2,100	–	–	0.13%	78
2019 Q4	$548K	Buy	+2,100	New	+$553K	0.11%	85

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Baxter Bros Inc's IDXX Position: Q2 2026 in Review

Baxter Bros Inc increased its Idexx Laboratories (IDXX) stake by 0.76% in Q2 2026, buying an estimated $7.29K and bringing the position to 1,723 shares worth $907K. The position accounts for 0.1% of the portfolio, ranked #98.

Baxter Bros Inc first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.27M in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Baxter Bros Inc held 1,723 shares of Idexx Laboratories worth $907K as of Q2 2026.
Baxter Bros Inc bought 13 Idexx Laboratories shares in Q2 2026, an estimated $7.29K.
Idexx Laboratories made up 0.1% of Baxter Bros Inc's portfolio in Q2 2026, its #98 holding.
Baxter Bros Inc first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
Baxter Bros Inc's Idexx Laboratories position peaked at $1.27M in Q4 2023.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.